Institutional Ownership
Revelation Biosciences Inc
CUSIP 76135L119*W EXP 01/10/202REVBWQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
10
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Linden Advisors LP | 338.1K | $2.6K |
| 2 | Toronto Dominion Bank | 99.5K | $896 |
| 3 | Wolverine Asset Management LLC | 54.8K | $498 |
| 4 | Jane Street Group, LLC | 50.0K | $388 |
| 5 | Soltis Investment Advisors LLC | 47.5K | $318 |
| 6 | Citadel Advisors LLC | 32.4K | $285 |
| 7 | Ubs Group AG | 532 | $4 |
| 8 | Quaker Wealth Management, LLC | 387 | $3 |
| 9 | Clear Street Group Inc. | 247.5K | $0 |
| 10 | T3 Companies, LLC | 198.1K | $0 |